Education
About Us
Working with TipRanks
Follow Us
Cognition Therapeutics (CGTX)
NASDAQ:CGTX
Active Comparator Ct1812
Age-Related Macular Degeneration
Phase II
Terminated
Study to Evaluate the Efficacy and Safety of Oral CT1812 in Participants With Geographic Atrophy (GA) Secondary to Dry Age-Related Macular Degeneration (AMD).
May 17, 2023
―
Ct1812
Early Alzheimer's Disease
Phase II
Active Not Recruiting
A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease
Aug 08, 2022
―
Ct1812
Dementia With Lewy Bodies
Phase II
Completed
Study to Evaluate the Safety, Tolerability and Efficacy of CT1812 in Subjects With Mild to Moderate Dementia With Lewy Bodies
Jan 11, 2022
―
Ct1812
Alzheimer Disease
Phase II
Completed
Pilot Clinical Study of CT1812 in Mild to Moderate Alzheimer's Disease Using EEG
Jan 30, 2020
―
Ct1812
Mild To Moderate Alzheimer's Disease
Phase II
Completed
A Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease.
Apr 10, 2018
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Cognition Therapeutics (CGTX) have in its pipeline
CGTX is currently developing the following drugs: Active Comparator Ct1812, Ct1812, Ct1812. These drug candidates are in various stages of clinical development as the company works toward FDA approval.